마이크로니들 약물전달 시스템 시장 규모, 점유율, 성장 분석 : 유형별, 재료별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Microneedle Drug Delivery Systems Market Size, Share, and Growth Analysis, By Type (Dissolving Microneedles, Hollow Microneedles), By Material (Ceramics, Metal), By Application, By End User, By Region - Industry Forecast 2025-2032
마이크로니들 약물전달 시스템 세계 시장 규모는 2023년에 54억 달러로 평가되었습니다. 2024년에는 57억 7,000만 달러에서 2032년에는 97억 6,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 6.8%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
마이크로니들 약물전달 시스템 시장은 기존의 피하 주사를 대체할 수 있는 안전한 주사제에 대한 수요 증가에 힘입어 강력한 성장세를 보이고 있습니다. 이러한 혁신적인 시스템은 안전 문제를 줄이고 환자, 의료 서비스 제공업체 및 규제 기관에 즉각적이고 장기적인 이점을 제공합니다. 연구 개발의 강화는 시장 확대를 더욱 촉진하고 있습니다. 마이크로니들 패치의 출현으로 예방 가능한 질병, 특히 전염성이 높아 효과적인 관리 대책이 필요한 홍역 예방접종에 대한 접근성이 간소화되고 개선되었습니다. 최소한의 교육을 받은 사람이라도 쉽게 접종할 수 있다는 점이 마이크로니들 솔루션의 매력을 더욱 높여줍니다. 전반적으로, 예방접종 및 기타 의료 응용 분야에서 마이크로니들 시스템의 장점에 대한 인식이 높아지면서 시장 성장에 크게 기여하고 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 규제 상황
- 사례 연구
- 기술 진보
- 특허 분석
마이크로니들 약물전달 시스템 시장 규모 : 유형별&CAGR(2025-2032년)
- 시장 개요
- 용해 마이크로니들
- 중공 마이크로니들
- 하이드로겔 형성 마이크로니들
- 솔리드 마이크로니들
- 기타
마이크로니들 약물전달 시스템 시장 규모 : 재료별&CAGR(2025-2032년)
마이크로니들 약물전달 시스템 시장 규모 : 용도별&CAGR(2025-2032년)
- 시장 개요
- 심장혈관
- 피부과
- 신경과
- 종양과
- 통증관리
마이크로니들 약물전달 시스템 시장 규모 : 최종사용자별&CAGR(2025-2032년)
마이크로니들 약물전달 시스템 시장 규모& CAGR(2025-2032년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 전년대비 매출 비교(2022-2024년)
주요 기업 개요
- Gerresheimer AG(Germany)
- Vetter Pharma-Fertigung GmbH & Co. KG(Germany)
- Catalent, Inc.(United States)
- FUJIFILM Diosynth Biotechnologies(United States)
- Hovione(Portugal)
- 3M Company(United States)
- Micron Biomedical(United States)
- Nanopass Technologies Ltd.(Israel)
- Zosano Pharma Corporation(United States)
- Medica Instrumenta(India)
- Mitsubishi Tanabe Pharma Corporation(Japan)
- Becton, Dickinson and Company(BD)(United States)
- Microneedle Technologies, Inc.(United States)
- Hapilabs(Singapore)
- MicronJet(United States)
- Mikrofill(United Kingdom)
- Microneedle Systems, Inc.(United States)
- Nanopatch(Australia)
- Vaxess Technologies(United States)
- Tandem Diabetes Care, Inc.(United States)
결론과 제안
LSH
Global Microneedle Drug Delivery Systems Market size was valued at USD 5.4 billion in 2023 and is poised to grow from USD 5.77 billion in 2024 to USD 9.76 billion by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).
The microneedle drug delivery systems market is witnessing robust growth, fueled by increasing demand for safer alternatives to traditional hypodermic injections. These innovative systems alleviate safety concerns and provide both immediate and long-term advantages for patients, healthcare providers, and regulatory bodies. Enhanced research and development efforts are further propelling market expansion. The emergence of microneedle patches has simplified and improved access to vaccinations for preventable diseases, notably measles, which requires effective control measures due to its high contagion rate. The ease of administration, even by minimally trained personnel, further enhances the appeal of microneedle solutions. Overall, heightened awareness of the advantages of microneedle systems in vaccinations and other medical applications is significantly driving market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microneedle Drug Delivery Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Microneedle Drug Delivery Systems Market Segments Analysis
Global Microneedle Drug Delivery Systems Market is segmented by Type, Material, Application, End User and region. Based on Type, the market is segmented into Dissolving Microneedles, Hollow Microneedles, Hydrogel-forming Microneedles, Solid Microneedles and Others. Based on Material, the market is segmented into Ceramics, Metal, Polymers and Silicon. Based on Application, the market is segmented into Cardiovascular, Dermatology, Neurology, Oncology and Pain Management. Based on End User, the market is segmented into Home Care Settings, Hospitals, Research Institutions and Speciality Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Microneedle Drug Delivery Systems Market
The increasing global population of the elderly is significantly propelling the need for more convenient and user-friendly drug delivery solutions, thereby enhancing the adoption of microneedle systems. As the demographic landscape shifts towards a higher proportion of older individuals, there is a growing emphasis on developing innovative medical technologies that simplify treatment processes. Microneedle drug delivery systems present a compelling solution, offering a less invasive and easier method of administration compared to traditional techniques. This trend is poised to accelerate as healthcare providers and patients alike seek efficient alternatives that cater to the specific needs of the aging population.
Restraints in the Global Microneedle Drug Delivery Systems Market
The Global Microneedle Drug Delivery Systems market faces a significant limitation due to the fact that not all medications can be effectively delivered using microneedle technology. This constraint restricts the variety of drugs that can be administered through these innovative systems. As a result, the potential applications and market growth for microneedle delivery methods are hindered, as only specific types of drugs are compatible with this delivery mechanism. This limitation may slow down advancements in the technology and reduce overall adoption rates in the healthcare sector, impacting the market's expansion and potential revenue generation.
Market Trends of the Global Microneedle Drug Delivery Systems Market
The Global Microneedle Drug Delivery Systems market is witnessing a significant trend driven by the increasing demand for pain-free and minimally invasive drug administration methods. As patients and healthcare providers seek alternatives to traditional injections, microneedle systems are emerging as a preferred solution due to their ability to deliver medications effectively with reduced pain and lower risk of infection. This shift is further supported by advancements in technology, enhancing the efficacy and versatility of microneedle applications across various therapeutic areas, including vaccines and chronic disease management. Consequently, the market is set to expand, reflecting a growing preference for innovative healthcare solutions.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Landscape
- Case Studies
- Technological Advancement
- Patent Analysis
Global Microneedle Drug Delivery Systems Market Size by Type & CAGR (2025-2032)
- Market Overview
- Dissolving Microneedles
- Hollow Microneedles
- Hydrogel-forming Microneedles
- Solid Microneedles
- Others
Global Microneedle Drug Delivery Systems Market Size by Material & CAGR (2025-2032)
- Market Overview
- Ceramics
- Metal
- Polymers
- Poly Lactic-co-Glycolic Acid
- Polylactic Acid
- Polyvinylpyrrolidone
- Silicon
Global Microneedle Drug Delivery Systems Market Size by Application & CAGR (2025-2032)
- Market Overview
- Cardiovascular
- Dermatology
- Neurology
- Oncology
- Pain Management
Global Microneedle Drug Delivery Systems Market Size by End User & CAGR (2025-2032)
- Market Overview
- Home Care Settings
- Hospitals
- Research Institutions
- Speciality Clinics
Global Microneedle Drug Delivery Systems Market Size & CAGR (2025-2032)
- North America (Type, Material, Application, End User)
- Europe (Type, Material, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Type, Material, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Type, Material, Application, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Type, Material, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vetter Pharma-Fertigung GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Catalent, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- FUJIFILM Diosynth Biotechnologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hovione (Portugal)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Micron Biomedical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nanopass Technologies Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zosano Pharma Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medica Instrumenta (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mitsubishi Tanabe Pharma Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microneedle Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hapilabs (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicronJet (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mikrofill (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microneedle Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nanopatch (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vaxess Technologies (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Tandem Diabetes Care, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
